A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age75+
SponsorSecond Affiliated Hospital of Wenzhou Medical University

About this trial

To observe and study the clinical effect of Huperzine A Injection on reducing postoperative delirium in elderly patients undergoing non-cardiac surgery

Eligibility criteria

Qualifiers

≥ 75 years old.

Comply with the indication of non-cardiac surgery under general anesthesia.

Anesthesia grade of American Society of Anesthesiologist (ASA) as III~IV grade.

The estimated operation time ≥ 2 hours.

Disqualifiers

Patients with impaired renal function (Cr is 1.5 times higher than the upper limit of the normal value of the central laboratory) or abnormal liver function (Alanine aminotransferase(ALT) and Aspartate aminotransferase(AST) are 2 times higher than the upper limit of the normal value of the central laboratory).

Patients who are positive for infectious diseases.

Patients accompanied with central nervous system injury.

Patients with previous history of delirium and epilepsy, long-term use of psychoactive drugs or preoperative assessment of delirium.

Trial design

Treatments tested in this trial

  • Sodium Chloride Injection
  • Huperzine A Injection

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Second Affiliated Hospital of Wenzhou Medical University

Lead sponsor

Affiliated Wenling Hospital of Wenzhou Medical University

Collaborator